Turner Christopher Durant

CIK 00018621461 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001862146

Recent Transactions

43 trades

Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2026-01-07+17,500→ 17,500 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-07+17,500→ 72,630 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-06$98.40/sh−225→ 55,130 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-06$97.33/sh−1,635→ 55,355 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-06$96.75/sh−1,321→ 56,990 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-05$98.52/sh−317→ 58,311 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-05$97.96/sh−1,929→ 58,628 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-05$96.85/sh−1,119→ 60,557 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-01-05$96.06/sh−871→ 61,676 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2025-01-06+37,500→ 37,500 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-01-06$78.28/sh−1,152→ 65,411 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-01-06+18,750→ 66,563 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-01-06$79.33/sh−691→ 64,720 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-01-06$80.54/sh−2,173→ 62,547 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2024-01-05+33,300→ 47,813 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2024-01-05+47,500→ 47,500 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$57.18/sh−500→ 15,978 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$57.70/sh−1,465→ 14,513 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$6.89/sh+7,995→ 22,508 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$51.32/sh−2,665→ 19,843 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$53.70/sh−2,265→ 17,578 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$54.32/sh−600→ 16,978 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-10-04$55.84/sh−500→ 16,478 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-10-04−7,995→ 303,105 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-07-28−2,665→ 311,100 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-28$6.89/sh+2,665→ 17,178 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-28$48.93/sh−2,665→ 14,513 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-26$6.89/sh+2,365→ 16,878 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-26$46.85/sh−2,365→ 14,513 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-07-26−2,365→ 313,765 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-24$6.89/sh+200→ 14,713 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-07-24−200→ 316,130 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-24$46.82/sh−200→ 14,513 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-07-20−100→ 316,330 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-20$46.80/sh−100→ 14,513 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-07-20$6.89/sh+100→ 14,613 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-06-05−10,235→ 316,430 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-06-05$6.89/sh+10,235→ 24,748 total
Sale
Nuvalent, Inc.$NUVL
Class A Common Stock
2023-06-05$44.86/sh−10,235→ 14,513 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-01-06+144,200→ 144,200 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2022-05-17−14,513→ 326,665 total
Exercise/Conversion
Nuvalent, Inc.$NUVL
Class A Common Stock
2022-05-17$6.89/sh+14,513→ 14,513 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2022-01-04+107,000→ 107,000 total

Companies

Nuvalent, Inc.
Chief Medical Officer
$NUVL

Recent Filings

Address

C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov